Latest News

Cardiac nuclear medicine offers critical value in managing heart disease by providing precise, non-invasive imaging that helps assess blood flow, detect blockages, and evaluate heart function. These insights guide treatment decisions, monitor therapy effectiveness, and improve patient outcomes, making it an essential tool in optimizing heart disease care.  In high-stakes environments like cardiac care, efficient […]

Radiology is frequently at the heart of the diagnostic process, providing essential insights that guide treatment decisions across nearly all areas of patient care. However, radiologists face significant challenges that limit their ability to deliver these insights efficiently and consistently. A major issue is the ongoing radiologist shortage, which restricts the service line’s capacity and [...]
Toronto, Ontario – The Newswire – July 10, 2024 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce  Ventripoint and ASCEND Cardiovascular, LLC a leading provider of cardiovascular IT solutions, have renewed and expanded the scope of their letter of intent. The two companies are collaborating in joint research and [...]

Jul 16, 2024

kforbes

Articles

0

CEO, Dr. Jeff Soble joins DAIC to discuss the forecast for telepresence and AI in hospitals. In this interview, he discusses how these technologies allow remote specialists and care team members to “be there, without being there” by creating a live, immersive, and information-rich environment for virtual, multi-disciplinary collaboration.  By combining state-of-the-art virtual communication technologies [...]
[Chicago, IL January 16,2023] – ASCEND Cardiovascular’s newest technology, Catalyst LIVE, currently implemented at two pioneering hospital sites, has pilots underway since 2022 at Stanford Medicine Children’s Health in California and Cook County Health in Illinois. Catalyst LIVE has prompted the expansion of this innovative technology into additional areas and campuses at these pilot sites [...]
Highlights of agreement ASCEND’s IT software is used by 50,000 hospitals, clinics, and caregivers. Initial two-year term for North American markets. Ventripoint will be integrated into ASCEND’s IT for cardiovascular care. Toronto, Ontario – December 12, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV: VPT; OTC: VPTDF), now bringing its AI-powered heart-scanning technology [...]
Toronto, Ontario – The Newswire – August 18, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and ASCEND Cardiovascular, LLC have developed a new integrated product. Today’s announcement marks a significant milestone in Ventripoint’s commitment to the collaboration between the two companies. ASCEND fits perfectly into [...]

Aug 22, 2023

gbrillon

Articles

0

Toronto, Ontario – The Newswire – August 10, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and Ascend Cardiovascular, a leading provider of cardiovascular IT solutions, have solidified a strategic collaboration. The two companies have signed a letter of intent to explore joint research and development [...]

Aug 14, 2023

gbrillon

Articles

0

ASCEND Cardiovascular, a leader in cardiovascular structured reporting and workflow innovation, announces the issuance of a patent by the United States Patent and Trademark Office (USPTO), covering its AI-based solution for Categorical Hanging Image Protocols (CHIP). Using AI-based image analysis and machine learning, CHIP automatically categorizes adult Transthoracic Echo (TTE) images by view/modality. This allows [...]
ASCEND Cardiovascular, leader in cardiovascular structured reporting and workflow solutions is partnering with Us2.ai to add fully automated echocardiography analysis and CV disease detection reporting to its suite of seamlessly integrated cardiovascular image visualization and reporting solutions. When integrated with InViewTM, ASCEND’s high-performance zero-footprint Cardiovascular viewer, Us2.ai’s FDA-cleared and CE Marked echocardiogram algorithms automate measurements and pre-populate [...]

May 16, 2023

gbrillon

Articles

0

0
0
image
https://ascendcv.com/wp-content/themes/blake/
https://ascendcv.com//
#0a2733
style1
paged
Loading posts...
/nas/content/live/ascendcvprod/
#
on
none
loading
#
Sort Gallery
https://ascendcv.com/wp-content/themes/blake
on
yes
yes
off
Enter your email here
off
off